Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-269 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-00 |
filingDate |
2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EA-201301300-A2 |
titleOfInvention |
PHARMACEUTICAL COMPOSITION IN THE FORM OF ORAL SUSPENSION THAT CONTAINS THE FLAVONOID FRACTURE AND XANTAN GUM |
abstract |
The pharmaceutical composition is in the form of an oral suspension that contains diosmin and xanthan gum. The use of the pharmaceutical composition according to the invention in the treatment of venous insufficiency. |
priorityDate |
2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |